Status | Study |
Not yet recruiting |
Study Name: Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers Condition: Adenoid Cystic Carcinoma Adnexal Carcinoma Apocrine Carcin Date: 2016-11-30 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Trial Evaluating Surgery With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Treating Patients With a High Risk of Developing Colorectal Peritoneal Carcinomatosis Condition: Malignant Neoplasm of Large Intestine TNM Staging Primary Tumor (T) T4 Metastases to Ovary Date: 2014-06-21 Interventions: Procedure: Surgery and Hyperthermic Intraperitoneal Chemotherapy with MMC HIPEC with MMC: Mitomycin C (M |
Completed |
Study Name: Signet Ring Cell Carcinoma in Esophageal Adenocarcinoma Condition: Adenocarcinoma Esophageal Cancer Date: 2013-04-02 |
Active, not recruiting |
Study Name: Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery Condition: Colon Mucinous Adenocarcinoma Colon Signet Ring Cell Adenocarcinoma Date: 2013-02-27 Interventions: Drug: Akt Inhibitor MK2206 Giv |
Completed |
Study Name: Prognosis of Signet Ring Cells in Upper Digestive Neoplasms Condition: Signet Ring Cell Carcinoma Stomach Disease Date: 2010-10-26 |
Recruiting |
Study Name: Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients Condition: Colorectal Cancer With a Resected Minimal Synchronous PC Ovarian Metastases Date: 2010-10-20 Interventions: Procedure: laparotomy plus HIPEC Laparotomy + HIPEC |
Terminated |
Study Name: Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer Condition: Colon Mucinous Adenocarcinoma Colon Signet Ring Cell Adenocarcinoma Date: 2010-09-09 Interventions: Biological: Cetuximab Given IV |
Active, not recruiting |
Study Name: Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer Condition: Colon Mucinous Adenocarcinoma Colon Signet Ring Cell Adenocarcinoma Date: 2005-09-20 Interventions: Biological: Bevacizumab Given |